Venlafaxine Hydrochloride
Product Images NDC 50090-4568

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-4568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904568)

Venlafaxine Hydrochloride 75 mg label from A-S Medication Solutions. The label indicates extended-release capsules, with each containing venlafaxine hydrochloride equivalent to 75 mg of venlafaxine. Storage instructions specify 68 to 77 degrees Fahrenheit. The package contains 29 extended-release unit dose capsules. NDC 50090-4568-0 is visible along with batch and manufacturing details.*

FDA Label Image

Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)

A forest plot chart displaying the pharmacokinetic (PK) fold changes and 90% confidence interval (CI) recommendations for venlafaxine interacting with various drugs. The chart lists interacting drugs, analyte types, PK parameters (Cmax, AUC), and shows fold change in PK parameters with recommendations such as 'Avoid concomitant use', 'No dose adjustment', 'Use with caution', or notes on clinical significance. The x-axis represents change relative to reference values.*

FDA Label Image

Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)

A pharmacokinetic interaction chart showing various drugs and their analytes with corresponding Cmax and AUC fold changes. The graph displays change relative to a reference value for each interacting drug with recommendations on dose adjustments or warnings such as 'Avoid concomitant use' and 'No dose adjustment'. Drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium with noted clinical significance for some interactions.*

FDA Label Image

Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)

A chart showing pharmacokinetic (PK) analysis of venlafaxine in special populations including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender. The chart depicts fold change and 90% confidence intervals for Cmax and AUC values, alongside dosage recommendations such as dose reductions or no adjustment.*

FDA Label Image

Chemical Structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride showing a cyclohexanol group attached to a methoxy phenyl group, with a dimethylaminoethyl side chain and HCl salt representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.